CVSI Analysis & News - CV Sciences, Inc. | Seeking Alpha

CVSI

CV Sciences, Inc. | OTCQB

1d 5d 1m 6m 1y 5y 10Y MAX Advanced Chart

52wk high:9.20

52wk low:1.10

EPS (FWD):0.12

PE (FWD):40.52

Div Rate (FWD):-

Yield (FWD):-

Market Cap:$459.74M

Volume:

Analysis

CV Sciences: Wish We Could Forget Your Troubled Past
Cornerstone Investments•Thu, Jan. 31•108 Comments
CV Sciences: The Marijuana Trade Of The Year
Wilsonville Capital•Dec. 19, 2018•106 Comments
Marijuana Stocks: 1,000% Gainers From My Seeking Alpha Portfolio - A Fun Back-Test
Anthony Cataldo•Oct. 8, 2018•50 Comments
13 Reasons Why I Am Buying CV Sciences
Special Situations and Arbs•Sep. 4, 2018•94 Comments
CV Sciences: Investors Should Watch These Risks
Wallace Lee•Aug. 28, 2018•189 Comments
Citron Pushes Down CV Sciences. Does It Make Sense?
Villamayor Capital•Aug. 21, 2018•114 Comments
CannaVest: Does This Sound Like A 'Pot Stock' To You?
Dallas Salazar•Jul. 6, 2015•20 Comments
CannaVest: Recent Financing And Strong Balance Sheet Differentiate This Cannabis Player
Dallas Salazar•Jun. 20, 2015•8 Comments
CannaVest Makes Big Non-Cash Profit And Terminates HempMedsPX
Rolling O Research•Aug. 18, 2014•18 Comments
Is CannaVest's Sky-High Valuation Justified?
Rolling O Research•Jan. 27, 2014•52 Comments

News

CV Sciences, Inc. SEC Filing - Quarterly Report (10-Q) May 9, 2019
SEC Filings•Thu, May 9
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2019 Results - Earnings Call Transcript
SA Transcripts•Wed, May 8
CV Sciences Q1 EPS misses; sees INDA late'19/early '20
SA News•Wed, May 8•11 Comments
CV Sciences misses by $0.01, beats on revenue
SA News•Wed, May 8•38 Comments
CV Sciences, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) April 26, 2019
SEC Filings•Fri, Apr. 26•1 Comment
CV Sciences appoints Joerg Grasser as new CFO
SA News•Fri, Mar. 22•8 Comments
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q4 2018 Results - Earnings Call Transcript
SA Transcripts•Tue, Mar. 12•29 Comments
CV Sciences, Inc. SEC Filing - Annual Report (10-K) March 12, 2019
SEC Filings•Tue, Mar. 12
CV Sciences EPS in-line, misses on revenue
SA News•Tue, Mar. 12•45 Comments
How do teen smoking risks affect pot stocks?
SA News•Thu, Feb. 14•134 Comments
DeSantis wants end to medical marijuana smoking ban
SA News•Fri, Jan. 18•49 Comments
NY Governor to back legal cannabis
SA News•Tue, Jan. 15•55 Comments
Shortable shares scarce in Tilray
SA News•Wed, Jan. 9•49 Comments
Cannabis analyst sees $80B U.S. market by 2030
SA News•Tue, Jan. 8•59 Comments
CV Sciences appoints new chief accounting officer
SA News•Tue, Jan. 8•3 Comments

More From Our Partners

CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
at Zacks.com (May 1, 2019)
CV Sciences Skewing Successfully Thanks To CBD Sales
at Benzinga (Mar 21, 2019)
US Hemp Authority Issues First 13 Certification Seals
at Benzinga (Mar 1, 2019)
Farm Bill Effect: Impact On U.S. And Global Hemp Markets
at Benzinga (Dec 14, 2018)
This Is The One Cannabis Stock NOT In A Downtrend Right Now
at Benzinga (Oct 30, 2018)